JO3430B1 - مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها - Google Patents
مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليهاInfo
- Publication number
- JO3430B1 JO3430B1 JOP/2016/0126A JOP20160126A JO3430B1 JO 3430 B1 JO3430 B1 JO 3430B1 JO P20160126 A JOP20160126 A JO P20160126A JO 3430 B1 JO3430 B1 JO 3430B1
- Authority
- JO
- Jordan
- Prior art keywords
- span
- dir
- ltr
- sub
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
يتعلق الاختراع الحالي بمركبات لها الصيغة (<span dir="LTR">I</span>)<span dir="LTR">:</span> حيث تكون <span dir="LTR">R<sub>1</sub></span>، <span dir="LTR">R<sub>2</sub></span>، <span dir="LTR">R<sub>5</sub></span>، <span dir="LTR">R<sub>6</sub></span>، <span dir="LTR">R<sub>7</sub></span>، <span dir="LTR">R<sub>12</sub></span>، <span dir="LTR">X</span>، <span dir="LTR">Y</span>، <span dir="LTR">A</span>، <span dir="LTR">E</span> و<span dir="LTR">n</span> مثلما تم تحديده في الوصف. الأدوية.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1555747A FR3037956B1 (fr) | 2015-06-23 | 2015-06-23 | Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3430B1 true JO3430B1 (ar) | 2019-10-20 |
Family
ID=54260901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2016/0126A JO3430B1 (ar) | 2015-06-23 | 2016-06-22 | مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها |
Country Status (42)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3037958B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037957B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037959B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| UY37342A (es) | 2016-07-22 | 2018-01-31 | Servier Lab | Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos |
| UY37560A (es) | 2017-01-06 | 2018-07-31 | Servier Lab | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta |
| JP7179733B2 (ja) | 2017-01-06 | 2022-11-29 | レ ラボラトワール セルヴィエ | Ｍｃｌ－１阻害剤及びタキサン化合物の組み合わせ物、その使用及び医薬組成物 |
| MA49444A (fr) | 2017-06-22 | 2020-04-29 | Servier Lab | Combinaison d'un inhibiteur de mcl-1 et d'un standard de traitement de soin pour cancers hématologiques, utilisations et compositions pharmaceutiques associées |
| KR20200041942A (ko) | 2017-08-15 | 2020-04-22 | 애브비 인코포레이티드 | 거대환식 mcl-1 저해제 및 이의 용도 |
| BR112020003130A2 (pt) * | 2017-08-15 | 2020-10-13 | AbbVie Deutschland GmbH & Co. KG | inibidores macrocíclicos de mcl-1 e métodos de uso |
| CN110964034B (zh) * | 2018-09-29 | 2022-04-12 | 江苏恒瑞医药股份有限公司 | 嘧啶并噻吩类衍生物、其制备方法及其在医药上的应用 |
| AR116635A1 (es) | 2018-10-15 | 2021-05-26 | Servier Lab | Proceso para la síntesis de derivados de piperazinil-etoxi-bromofenilo y su aplicación en la producción de compuestos que los contienen |
| TWI849001B (zh) | 2018-11-14 | 2024-07-21 | 法商施維雅藥廠 | Mcl-1抑制劑及米哚妥林(midostaurin)之組合，其用途及醫藥組合物 |
| CN111187277B (zh) * | 2018-11-14 | 2022-04-12 | 江苏恒瑞医药股份有限公司 | 噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用 |
| PY2020118A (es) | 2019-05-20 | 2022-10-27 | Servier Lab | Conjugados de anticuerpo-fármaco inhibidores de mcl-1 y sus métodos de uso |
| TW202114682A (zh) | 2019-06-17 | 2021-04-16 | 法商施維雅藥廠 | Mcl-1抑制劑與乳癌標準療法之組合，其用途及醫藥組合物 |
| CN112457308B (zh) | 2019-09-09 | 2024-01-02 | 上海长森药业有限公司 | 新型三环芳香杂环化合物，及其制备方法、药物组合物和应用 |
| CN117136076A (zh) | 2020-11-24 | 2023-11-28 | 诺华股份有限公司 | Mcl-1抑制剂抗体药物缀合物和使用方法 |
| EP4351564A1 (en) | 2021-06-11 | 2024-04-17 | Gilead Sciences, Inc. | Combination mcl-1 inhibitors with anti-cancer agents |
| CA3222752A1 (en) | 2021-06-11 | 2022-12-15 | Gilead Sciences, Inc. | Combination mcl-1 inhibitors with anti-body drug conjugates |
| US20250387504A1 (en) | 2022-05-20 | 2025-12-25 | Novartis Ag | Antibody-drug conjugates of antineoplastic compounds and methods of use thereof |
| TW202540185A (zh) | 2023-11-22 | 2025-10-16 | 法商施維雅藥廠 | 抗cd74抗體藥物結合物及其使用方法 |
| WO2025111431A1 (en) | 2023-11-22 | 2025-05-30 | Les Laboratoires Servier | Anti-cd7 antibody-drug conjugates and methods of use thereof |
| WO2025126157A1 (en) | 2023-12-15 | 2025-06-19 | Advesya | Anti-il-1rap binding domains and antibody-drug conjugates thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL96531A (en) * | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
| DE10058663A1 (de) * | 2000-11-25 | 2002-05-29 | Merck Patent Gmbh | Verwendung von Thienopyrimidinen |
| WO2007056214A2 (en) * | 2005-11-02 | 2007-05-18 | Cytovia, Inc | N-alkyl-n-aryl-thienopyrimidin-r-amines and uses thereof |
| CA2722220C (en) * | 2008-04-30 | 2016-06-07 | National Health Research Institutes | Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
| WO2012044993A1 (en) * | 2010-09-30 | 2012-04-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders |
| CN102464667B (zh) * | 2010-11-03 | 2014-06-04 | 中国科学院上海药物研究所 | 一类五元杂环并嘧啶类化合物及其制备方法和用途 |
| AR084294A1 (es) * | 2010-12-20 | 2013-05-08 | Glenmark Pharmaceuticals Sa | Compuestos de 2-amino-4-ariltiazol, metodos para su sintesis y uso como antagonista de trpa1 |
| AR090037A1 (es) * | 2011-11-15 | 2014-10-15 | Xention Ltd | Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio |
| FR2986002B1 (fr) | 2012-01-24 | 2014-02-21 | Servier Lab | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP2922858A4 (en) * | 2012-11-20 | 2016-06-15 | Univ Mcgill | THIENOPYRIMIDININHIBITORS OF FARNESYL AND / OR GERANYL GERANYL PYROPHOSPHATE SYNTHASE |
| FR3015483B1 (fr) * | 2013-12-23 | 2016-01-01 | Servier Lab | Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037959B1 (fr) * | 2015-06-23 | 2017-08-04 | Servier Lab | Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037957B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3037958B1 (fr) * | 2015-06-23 | 2019-01-25 | Les Laboratoires Servier | Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3046792B1 (fr) * | 2016-01-19 | 2018-02-02 | Les Laboratoires Servier | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2015
- 2015-06-23 FR FR1555747A patent/FR3037956B1/fr not_active Expired - Fee Related
-
2016
- 2016-06-16 UY UY0001036733A patent/UY36733A/es unknown
- 2016-06-22 HK HK18109702.0A patent/HK1250234A1/zh unknown
- 2016-06-22 EA EA201890123A patent/EA034587B1/ru unknown
- 2016-06-22 UA UAA201800620A patent/UA123267C2/uk unknown
- 2016-06-22 HK HK18111502.8A patent/HK1252113B/en unknown
- 2016-06-22 US US15/737,783 patent/US10457687B2/en active Active
- 2016-06-22 EP EP16731158.8A patent/EP3313850B1/en active Active
- 2016-06-22 HR HRP20181806TT patent/HRP20181806T1/hr unknown
- 2016-06-22 CR CR20170571A patent/CR20170571A/es unknown
- 2016-06-22 DK DK16731158.8T patent/DK3313850T3/en active
- 2016-06-22 CR CR20170590A patent/CR20170590A/es unknown
- 2016-06-22 SI SI201630123T patent/SI3313850T1/sl unknown
- 2016-06-22 PT PT16731158T patent/PT3313850T/pt unknown
- 2016-06-22 MX MX2017016996A patent/MX368845B/es active IP Right Grant
- 2016-06-22 JP JP2017566280A patent/JP6741698B2/ja active Active
- 2016-06-22 CA CA2990089A patent/CA2990089C/en active Active
- 2016-06-22 MY MYPI2017704883A patent/MY189472A/en unknown
- 2016-06-22 KR KR1020187002016A patent/KR102620905B1/ko active Active
- 2016-06-22 MA MA42232A patent/MA42232B1/fr unknown
- 2016-06-22 PE PE2017002702A patent/PE20190111A1/es unknown
- 2016-06-22 LT LTEP16731158.8T patent/LT3313850T/lt unknown
- 2016-06-22 CU CUP2017000164A patent/CU20170164A7/xx unknown
- 2016-06-22 AU AU2016282837A patent/AU2016282837B2/en active Active
- 2016-06-22 RS RS20181327A patent/RS57961B1/sr unknown
- 2016-06-22 MD MDE20180440T patent/MD3313850T2/ro unknown
- 2016-06-22 ES ES16731158T patent/ES2703997T3/es active Active
- 2016-06-22 WO PCT/EP2016/064436 patent/WO2016207226A1/en not_active Ceased
- 2016-06-22 PL PL16731158T patent/PL3313850T3/pl unknown
- 2016-06-22 JO JOP/2016/0126A patent/JO3430B1/ar active
- 2016-06-22 GE GEAP201614679A patent/GEP20207075B/en unknown
- 2016-06-22 TW TW105119598A patent/TWI631124B/zh active
- 2016-06-22 GE GEAP201914679A patent/GEAP201914679A/en unknown
- 2016-06-22 RU RU2018102372A patent/RU2747673C2/ru active
- 2016-06-22 CN CN201680039612.9A patent/CN107709334B/zh active Active
- 2016-06-22 TN TNP/2017/000521A patent/TN2017000521A1/en unknown
- 2016-06-23 AR ARP160101879A patent/AR105101A1/es active IP Right Grant
-
2017
- 2017-12-07 IL IL256191A patent/IL256191B/en active IP Right Grant
- 2017-12-11 PH PH12017502266A patent/PH12017502266B1/en unknown
- 2017-12-11 CL CL2017003163A patent/CL2017003163A1/es unknown
- 2017-12-12 SV SV2017005588A patent/SV2017005588A/es unknown
- 2017-12-13 CO CONC2017/0012830A patent/CO2017012830A2/es unknown
- 2017-12-14 EC ECIEPI201782546A patent/ECSP17082546A/es unknown
- 2017-12-21 SA SA517390583A patent/SA517390583B1/ar unknown
-
2018
- 2018-12-10 CY CY181101321T patent/CY1120991T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JO3430B1 (ar) | مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| PH12020551089A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| JO3807B1 (ar) | مشتقات حمض هيدروكسي جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها | |
| TN2017000524A1 (en) | New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| TN2018000395A1 (en) | New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| EA201892838A1 (ru) | Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их | |
| EA201891103A1 (ru) | Композиции для лечения спинальной мышечной атрофии | |
| WO2016105564A8 (en) | Quinazoline derivatives used to treat hiv | |
| EA201692280A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
| MX376028B (es) | Nuevos derivados de amonio, un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| MX376833B (es) | Oxiesteroles y metodos de uso de los mismos. | |
| EA201891063A1 (ru) | Производные дигидроимидазопиразинона, применимые в лечении рака | |
| MX378732B (es) | Formas solidas novedosas | |
| EA201892246A1 (ru) | Производные аминотиазола, полученные в качестве противовирусных средств | |
| EA201791896A1 (ru) | Дезацетокситубулизин н и его аналоги | |
| EA202090978A1 (ru) | Новые макроциклические производные, способ их получения и содержащие их фармацевтические композиции | |
| EA201690390A1 (ru) | Производные амидов в качестве антагонистов рецептора к лизофосфатидной кислоте | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| EA201890534A1 (ru) | Новые аннелированные феноксиацетамиды | |
| EA201791600A1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
| PH12015502632A1 (en) | Cxcr7 receptor modulators | |
| PH12019500822B1 (en) | Crystalline forms of eravacycline | |
| JO3742B1 (ar) | مركب بيرانو داي بيريدين |